118 related articles for article (PubMed ID: 7735558)
1. Correlation of p-glycoprotein detection by immunohistochemistry with mdr-1 mRNA levels in osteosarcomas. Pilot study.
Kandel RA; Campbell S; Noble-Topham S; Bell R; Andrulis IL
Diagn Mol Pathol; 1995 Mar; 4(1):59-65. PubMed ID: 7735558
[TBL] [Abstract][Full Text] [Related]
2. Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators.
Charpin C; Vielh P; Duffaud F; Devictor B; Andrac L; Lavaut MN; Allasia C; Horschowski N; Piana L
J Natl Cancer Inst; 1994 Oct; 86(20):1539-45. PubMed ID: 7932810
[TBL] [Abstract][Full Text] [Related]
3. [P-glycoprotein expression in osteosarcoma].
Pösl M; Grahl K; Amling M; Werner M; Ritzel H; Stenzel I; Hentz M; Winkler K; Delling G
Pathologe; 1996 Jan; 17(1):50-5. PubMed ID: 8685096
[TBL] [Abstract][Full Text] [Related]
4. Expression of MDR1/p-glycoprotein and multidrug resistance-associated protein in childhood solid tumours.
Oda Y; Röse I; Radig K; Wagemann W; Mittler U; Roessner A
Virchows Arch; 1997 Feb; 430(2):99-105. PubMed ID: 9083512
[TBL] [Abstract][Full Text] [Related]
5. Expression of transforming growth factor beta isoforms in osteosarcoma variants: association of TGF beta 1 with high-grade osteosarcomas.
Franchi A; Arganini L; Baroni G; Calzolari A; Capanna R; Campanacci D; Caldora P; Masi L; Brandi ML; Zampi G
J Pathol; 1998 Jul; 185(3):284-9. PubMed ID: 9771482
[TBL] [Abstract][Full Text] [Related]
6. Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.
Oda Y; Ohishi Y; Saito T; Hinoshita E; Uchiumi T; Kinukawa N; Iwamoto Y; Kohno K; Kuwano M; Tsuneyoshi M
J Pathol; 2003 Feb; 199(2):251-8. PubMed ID: 12533839
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of multidrug resistance gene expression in human osteosarcomas.
Lee PD; Noble-Topham SE; Bell RS; Andrulis IL
Br J Cancer; 1996 Oct; 74(7):1046-50. PubMed ID: 8855972
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic MDR-1 gene and P-glycoprotein expression in human melanoma cell lines.
Berger W; Elbling L; Minai-Pour M; Vetterlein M; Pirker R; Kokoschka EM; Micksche M
Int J Cancer; 1994 Dec; 59(5):717-23. PubMed ID: 7960246
[TBL] [Abstract][Full Text] [Related]
9. Relationship between P-glycoprotein positivity, doxorubicin binding ability and histologic response to chemotherapy in osteosarcomas.
Kusuzaki K; Hirata M; Takeshita H; Murata H; Hashiguchi S; Ashihara T; Hirasawa Y
Cancer Lett; 1999 Apr; 138(1-2):203-8. PubMed ID: 10378794
[TBL] [Abstract][Full Text] [Related]
10. Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs.
Stein U; Walther W; Wunderlich V
Eur J Cancer; 1994; 30A(10):1541-5. PubMed ID: 7833115
[TBL] [Abstract][Full Text] [Related]
11. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
12. High expression of MDR-1 gene and P-glycoprotein in initial and re-biopsy specimens of relapsed B-cell lymphoma.
Liu Q; Ohshima K; Kikuchi M
Histopathology; 2001 Mar; 38(3):209-16. PubMed ID: 11260300
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric assessment of multidrug resistance (MDR) phenotype in acute myeloid leukaemia.
Hart SM; Ganeshaguru K; Lyttelton MP; Prentice HG; Hoffbrand AV; Mehta AB
Leuk Lymphoma; 1993 Oct; 11(3-4):239-48. PubMed ID: 7903178
[TBL] [Abstract][Full Text] [Related]
14. p53 may mediate the mdr-1 expression via the WT1 gene in human vincristine-resistant leukemia/lymphoma cell lines.
Hirose M; Kuroda Y
Cancer Lett; 1998 Jul; 129(2):165-71. PubMed ID: 9719458
[TBL] [Abstract][Full Text] [Related]
15. mdr1 mRNA expression by RT-PCR in patients with primary breast cancer submitted to neoadjuvant therapy.
Wang CS; LaRue H; Fortin A; Gariépy G; Têtu B
Breast Cancer Res Treat; 1997 Aug; 45(1):63-74. PubMed ID: 9285118
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy induces or increases expression of multidrug resistance-associated protein in malignant melanoma cells.
Ichihashi N; Kitajima Y
Br J Dermatol; 2001 Apr; 144(4):745-50. PubMed ID: 11298532
[TBL] [Abstract][Full Text] [Related]
17. Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines.
Herzog CE; Trepel JB; Mickley LA; Bates SE; Fojo AT
J Natl Cancer Inst; 1992 May; 84(9):711-6. PubMed ID: 1349044
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
19. Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcoma.
Serra M; Maurici D; Scotlandi K; Barbanti-Brodano G; Manara MC; Benini S; Picci P; Bertoni F; Bacci G; Sottili S; Baldini N
Int J Oncol; 1999 Feb; 14(2):301-7. PubMed ID: 9917506
[TBL] [Abstract][Full Text] [Related]
20. Expression of a multidrug resistance gene in human rheumatoid synovium.
Jorgensen C; Sun R; Rossi JF; Costes J; Richard D; Bologna C; Sany J
Rheumatol Int; 1995; 15(2):83-6. PubMed ID: 7481486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
